Article

AMO concludes Pfizer acquisition

Advanced Medical Optics Inc. (AMO) completed its previously announced $450 million all-cash acquisition of Pfizer Ophthalmic's surgical business.

Related Videos
4 experts are featured in this series.
4 experts are featured in this series.
Related Content
Updates on EXG102 and EXG202 for wet AMD from Exegenesis Bio
December 11th 2024

Updates on EXG102 and EXG202 for wet AMD from Exegenesis Bio

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Bausch + Lomb acquires ELIOS system, expanding glaucoma treatment options
December 11th 2024

Bausch + Lomb acquires ELIOS system, expanding glaucoma treatment options

Robert Chang, MD, discusses the impact of large language models on glaucoma care and AI in ophthalmology
November 5th 2024

Innovation Series: Putting the buzz of large language models in ophthalmology into perspective with Robert T. Chang, MD

Survey highlights gender and racial disparities in ophthalmology
December 10th 2024

Survey highlights gender and racial disparities in ophthalmology

Nona Biosciences and Kodiak Sciences partner to develop novel antibodies for ophthalmic diseases
December 10th 2024

Nona Biosciences and Kodiak Sciences partner to develop novel antibodies for ophthalmic diseases

© 2024 MJH Life Sciences

All rights reserved.